AstraZeneca Moves Some Production To US Amid Tariff Threat
London: British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump’s possible tariffs on the sector. “Our company is firmly committed to investing and growing in the US,” chief executive Pascal Soriot said in an earnings statement, which also reported…
